Apostrophe - About the company
Apostrophe is an acquired company based in Oakland (United States), founded in 2012 by Ben Holber and Ryan Hambley. It operates as a Provide of an online platform for dermatology diagnosis and treatment. Apostrophe has raised an undisclosed amount in funding from 500 Global and FJ Labs. The company has 77 active competitors, including 7 funded and 10 that have exited. Its top competitors include companies like Alto, Thirty Madison and Icebreaker Health.
Company Details
Apostrophe offers an online platform for treating skin diseases. The user can take pictures of the skin condition and send it via the platform which is diagnosed by professionals. The professionals provide personalized treatment plans or prescriptions are sent to the user's address.
- Website
- apostrophe.com
- Email ID
- *****@apostrophe.com
- Registered Address
- 330 2nd St. STE# 201 Oakland CA 94607
Key Metrics
Founded Year
2012
Location
Oakland, United States
Stage
Acquired
Latest Funding Round
Investors
Ranked
9th among 77 active competitors
Employee Count
15 as on Aug 31, 2026
Exit Details
Acquired by Hims (Jun 24, 2021)
Legal entities associated with Apostrophe
Apostrophe is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Apostrophe Apps, LLC CIN: 1611302 , United States, Active | $1 - $1M (As on Jun 13, 2014) | - | - | |
APOSTROPHE, INC. CIN: 813126593 , United States, Active | Jun 13, 2016 | - | 61 (As on Dec 31, 2020) | - |
Apostrophe's acquisition details
Apostrophe got acquired by Hims on Jun 24, 2021.
Click here to take a look at Apostrophe's acquisition in detail
Sign up to download Apostrophe's company profile
Apostrophe's funding and investors
Apostrophe has raised funding over 2 rounds. Its first funding round was on Jan 27, 2016. Its latest funding round was a Seed round on Dec 2019 for $*****. 1 investor participated in its latest round. Apostrophe has 4 institutional investors.
Here is the list of recent funding rounds of Apostrophe:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 2019 | 9120464 | Seed | 8166144 | 9776430 | 5962979 | 7622984 |
Jan 27, 2016 | 5820744 | Seed | 8049383 | 1895725 | 3763079 |
View details of Apostrophe's funding rounds and investors
Apostrophe's founders and board of directors
Founder? Claim ProfileHere are the details of Apostrophe's key team members:
- Ben Holber: Co-Founder & CEO of Apostrophe. Contact Info: 1 email address
- Ryan Hambley: Co-Founder, Chief Product Officer of Apostrophe.
View details of Apostrophe's Founder profiles and Board Members
Apostrophe's employee count trend
Apostrophe has 15 employees as of Aug 26. Here is Apostrophe's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Apostrophe's Competitors and alternates
Top competitors of Apostrophe include Alto, Thirty Madison and Icebreaker Health. Here is the list of Top 10 competitors of Apostrophe, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alto 2015, San Francisco (United States), Acquired | Online pharmacy offering prescription delivery services | $592M | 75/100 | |
2nd | Thirty Madison 2017, New York City (United States), Acquired | Healthcare platform offers various brands and personalized treatments | $210M | 66/100 | |
3rd | Icebreaker Health 2014, San Francisco (United States), Acquired | Provider of remote patient consultation services and online delivery of medical care products | $64.7M | 63/100 | |
4th | Nurx 2015, San Francisco (United States), Series C | Online medication delivery company | $95.9M | 59/100 | |
5th | PipelineRx 2009, San Francisco (United States), Acquired | Clinical telepharmacy services and software solutions for optimized medication management | $27.3M | 46/100 | |
6th | JRNYS 2022, Austin (United States), Series A | Health and wellness platform that focuses on individualized treatment plans | $15.8M | - | 43/100 |
7th | ZappRx 2012, Cambridge (United States), Acquired | Specialty pharmacy care coordination platform | $32.6M | 41/100 | |
8th | Medly Pharmacy 2017, Brooklyn (United States), Deadpooled | Online pharmacy for selling prescribed medicines | $100M | 37/100 | |
9th | Apostrophe 2012, Oakland (United States), Acquired | Provide of an online platform for dermatology diagnosis and treatment | - | 37/100 | |
10th | Simple Online Pharmacy 2012, Glasgow (United Kingdom), Unfunded | Online health consultation and telepharmacy | - | - | 36/100 |
Looking for more details on Apostrophe's competitors? Click here to see the top ones
Apostrophe's Investments and acquisitions
Apostrophe has made no investments or acquisitions yet.
Reports related to Apostrophe
Here is the latest report on Apostrophe's sector:
News related to Apostrophe
•
•
•
•
Hims & Hers Acquires Teledermatology Platform ApostropheHIT Consultant•Jun 25, 2021•Hims, Apostrophe
•
•
Are you a Founder ?
FAQs about Apostrophe
Explore our recently published companies
- Naturia Professional - Pompano Beach based, 2007 founded, Public company
- Urban Tree Doctor - Orlando based, 2012 founded, Unfunded company
- Bccsa - Unfunded company
- Ceretti Team - Unfunded company
- LiveXP - Cyprus based, 2019 founded, Public company
- Sui Generis - Croatia based, Unfunded company